Shirley Liu, PhD
Director, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Professor, Biostatistics and Computational Biology, Harvard T.H. Chan School of Public Health
Dr. Liu has extensive experience in bioinformatics algorithm development and data integration of cancer genomics, including methods to identify transcriptional regulators from chromatin dynamics or differentially expressed genes, identify regulators of drug response and resistance from CRISPR screens, estimate tumor infiltrating immune cells, infer immune repertoires from tumor bulk or single-cell RNA-seq data, and predict tumor response to targeted therapy and immunotherapy.